Catapult Pharmacology
Sulfonamides
Sulfonamides are a group of antibiotics that work by decreasing the synthesis of purines and pyrimidines by competing with PABA (p-aminobenzoic acid) in the production of dihydrofolic acid, which is used in the synthesis of proteins and DNA. Blood dyscrasias, hypersensitivity syndromes including Stevens-Johnson syndrome, crystalluria and nephrotoxicity, and drug-drug reactions can occur.
Trimethoprim is combined with sulfamethoxazole in a single form and works by inhibition of dihydrofolate reductase, which is an enzyme in the production of purines, thymidine, and amino acids. Resistance from altered dihydrofolate reductase can occur. Toxicity occurs from folic acid deficiency and includes megaloblastic anemia and granulocytopenia.
Class Drugs
Trimethoprim/Sulfamethoxazole
Sulfasalazine
Silver sulfadiazine
Class Mechanism of Action
Sulfonamide Mechanism:
- Decreases synthesis of purines and pyrimidines by competing with PABA (p-aminobenzoic acid), which is used by bacteria in the production of dihydrofolic acid. Dihydrofolic acid is used for the next step of production of proteins, DNA precursors, etc.
Trimethoprim Mechanism:
- Inhibits dihydrofolate reductase, which is the next step in production of purines, thymidine, and amino acid synthesis after the production of dihydrofolic acid
Dihydrofolate reductase converts dihydrofolic acid to tetrahydrofolic acid, which is used in the production of proteins, DNA precursors, etc.
Bacteriostatic
Class Applications
See individual drugs
Class Adverse Effects
Resistance
Altered dihydrofolate reductase decreases affinity for trimethoprim
Efflux pumps
Decreased uptake
Sulfonamide specific adverse effects:
- Crystalluria
Prevention with adequate hydration and alkalinized urine
May lead to nephrotoxicity
Hypersensitivity
Stevens-Johnson syndrome
Angioedema, rash
Hemolytic anemia
Increased risk in patients with glucose-6-phosphate deficiency (G6PD)
- Blood dyscrasias
Aplastic anemia
Agranulocytosis
Thrombocytopenia
Granulocytopenia
Drug-drug interactions
Displaces warfarin and methotrexate from albumin binding site leading to increased serum levels
- Kernicterus
Avoid in pregnant women near term and newborns
Trimethoprim specific adverse effects
- Signs of folic acid deficiency
Megaloblastic anemia
Granulocytopenia
Avoided by co-administration of folinic acid, which does not go into the bacteria
Drug Table
| Drug Name | Application | Comments | Image |
|---|---|---|---|
| Trimethoprim/Sulfamethoxazole | MRSA skin infections; Respiratory infections; -H. influenzae; -Pneumocystis jirovecii pneumonia (formerly PCP pneumonia); Opportunistic infection in AIDS; Prophylaxis initiated with CD4 count less than 200; Listeria monocytogenes; Urinary tract infections; GI infections; Nontyphoid salmonella; Shigellosis | "Triangle" "Meth" "Sulfur" "Meth" "Ox" | |
| Sulfasalazine | Chronic inflammatory bowel disease (Ulcerative colitis, Crohn's) | Not an orally absorbed drug; Metabolized by gut flora; Metabolite exerts anti-inflammatory effect | "Sulfur" "Salamander" |
| Silver Sulfadiazine | Prevents topical infection in burns | "Silver" "Sulfur" "Die" |